Related Experiment Video
Updated: Apr 20, 2026
Matrix-assisted Autologous Chondrocyte Transplantation for Remodeling and Repair of Chondral Defects in a Rabbit Model
Published on: May 21, 2013
Cell-based articular cartilage repair: the link between development and regeneration
1The Harrington Laboratory for Molecular Orthopedics, Department of Orthopedic Surgery, University of Kansas Medical Center, Kansas City, KS, USA.
Abstract:
Clinical efforts to repair damaged articular cartilage (AC) currently face major obstacles due to limited intrinsic repair capacity of the tissue and unsuccessful biological interventions. This highlights a need for better therapeutic strategies. This review summarizes the recent advances in the field of cell-based AC repair. In both animals and humans, AC defects that penetrate into the subchondral bone marrow are mainly filled with fibrocartilaginous tissue through the differentiation of bone marrow mesenchymal stem cells (MSCs), followed by degeneration of repaired cartilage and osteoarthritis (OA). Cell therapy and tissue engineering techniques using culture-expanded chondrocytes, bone marrow MSCs, or pluripotent stem cells with chondroinductive growth factors may generate cartilaginous tissue in AC defects but do not form hyaline cartilage-based articular surface because repair cells often lose chondrogenic activity or result in chondrocyte hypertrophy. The new evidence that AC and synovium develop from the same pool of precursors with similar gene profiles and that synovium-derived chondrocytes have stable chondrogenic activity has promoted use of synovium as a new cell source for AC repair. The recent finding that NFAT1 and NFAT2 transcription factors (TFs) inhibit chondrocyte hypertrophy and maintain metabolic balance in AC is a significant advance in the field of AC repair. The use of synovial MSCs and discovery of upstream transcriptional regulators that help maintain the AC phenotype have opened new avenues to improve the outcome of AC regeneration.
Insights
Articular cartilage repair faces challenges due to limited healing capacity. New strategies using synovial stem cells and understanding transcription factors show promise for regenerating healthy cartilage.
Area of Science:
- Orthopedics
- Regenerative Medicine
- Biotechnology
Background:
- Articular cartilage (AC) has limited intrinsic repair capacity, hindering clinical treatments.
- Current cell-based therapies often fail to produce hyaline cartilage, leading to degeneration and osteoarthritis (OA).
- Existing methods using bone marrow mesenchymal stem cells (MSCs) or chondrocytes result in fibrocartilage or hypertrophy.
Purpose of the Study:
- To review recent advancements in cell-based articular cartilage repair strategies.
- To highlight novel cell sources and molecular targets for improved AC regeneration.
- To discuss the potential of synovial stem cells and transcriptional regulators in AC repair.
Main Methods:
- Literature review of current research in articular cartilage repair.
- Analysis of studies on cell sources, including chondrocytes, bone marrow MSCs, pluripotent stem cells, and synovial cells.
- Examination of findings related to chondrocyte hypertrophy and metabolic balance in AC.
Main Results:
- Synovium-derived chondrocytes demonstrate stable chondrogenic activity, offering a promising alternative cell source.
- Transcription factors NFAT1 and NFAT2 are identified as key regulators inhibiting chondrocyte hypertrophy and maintaining AC homeostasis.
- The use of synovial MSCs and understanding of regulatory pathways present new avenues for AC regeneration.
Conclusions:
- Synovium represents a viable and effective cell source for articular cartilage repair.
- Targeting specific transcription factors like NFAT1/NFAT2 can prevent chondrocyte hypertrophy and promote hyaline cartilage formation.
- Advances in cell sourcing and molecular regulation offer improved therapeutic strategies for AC regeneration and OA prevention.
